Top 27 Altcoins: Crypto Banter Founder Reveals Low-Risk Picksby John Darbie 24.06.2024Discover Ran Neuner's top 27 Ethereum-based low-risk, high-return altcoins poised for significant growth in the next bull run. Learn more ...
Euro 2024 Tech Aids Referees, But Can’t Solve Everythingby Lilu Anderson 24.06.2024Euro 2024 brings cutting-edge tech like connected balls and SAOT to aid referees, but subjective calls and controversies remain inevitable.
Bitcoin Collapse and S&P 500: A Looming Stock Decline?by John Darbie 24.06.2024"Crypto analysts link Bitcoin's drop to a potential S&P 500 decline, citing historical correlations and Federal Reserve policies. Discover market ...
Metasphere Labs & ARCannabis to Develop VR Virtual Storeby Lilu Anderson 22.06.2024Metasphere Labs and ARCannabis partner to create a VR virtual store, revolutionizing the online cannabis shopping experience with cutting-edge technology.
Cybersecurity Tops SME Concerns; AI Investment Varies Widelyby Lilu Anderson 21.06.2024Azets report reveals cybersecurity as top concern for Irish SMEs; recruitment set for largest investment, micro businesses lag in AI ...
Bitcoin’s $100K Target Feasible Amid ETF Approval Boostby John Darbie 21.06.2024"Experts affirm Bitcoin's $100K target is feasible, influenced by rate cuts, market dynamics, and growing institutional interest."
Cryptocurrency Correction: Trouble Ahead or Temporary Dip?by John Darbie 20.06.2024Cryptocurrency market corrections raise concerns as Bitcoin decouples from tech stocks, influenced by Fed policies and shifting investor focus.
Crypto Assets Soar: BTC Hits $66K Amid ETF Debut on ASXby John Darbie 20.06.2024Crypto assets rise as Bitcoin hits $66K, VanEck Bitcoin ETF debuts on ASX, and AI-linked tokens surge 35% amid Nvidia ...
US FDIC Chair Nominee Faces Potentially Delayed Confirmationby Mark Eisenberg 19.06.2024Christy Goldsmith Romero is expected to be confirmed as FDIC chair despite potential delays from Republican opposition and Senate procedural ...
Biotech’s Big Gamble Fails: Insights and Implicationsby Lilu Anderson 18.06.2024Catch up on biotech headlines: Zentalis faces FDA hold, Aerovate's major setback, Merck's new vaccine, and promising trials by Intra-Cellular ...